Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022

SELL
$0.69 - $1.21 $1,063 - $1,864
-1,541 Reduced 17.04%
7,500 $7,000
Q1 2022

May 05, 2022

SELL
$1.02 - $3.8 $519 - $1,934
-509 Reduced 5.33%
9,041 $9,000
Q4 2021

Jan 21, 2022

SELL
$3.26 - $4.66 $2,409 - $3,443
-739 Reduced 7.18%
9,550 $30,000
Q3 2021

Nov 08, 2021

SELL
$4.08 - $5.66 $41,024 - $56,911
-10,055 Reduced 49.42%
10,289 $45,000
Q2 2021

Aug 04, 2021

SELL
$5.01 - $7.48 $120,560 - $179,998
-24,064 Reduced 54.19%
20,344 $109,000
Q1 2021

May 10, 2021

BUY
$7.19 - $14.95 $304,172 - $632,459
42,305 Added 2011.65%
44,408 $331,000
Q4 2020

Feb 08, 2021

SELL
$6.66 - $14.66 $110,849 - $244,001
-16,644 Reduced 88.78%
2,103 $22,000
Q3 2020

Nov 09, 2020

BUY
$8.69 - $14.47 $85,057 - $141,632
9,788 Added 109.25%
18,747 $165,000
Q2 2020

Aug 05, 2020

BUY
$5.21 - $11.03 $35,704 - $75,588
6,853 Added 325.4%
8,959 $95,000
Q1 2020

May 06, 2020

BUY
$4.46 - $9.2 $9,392 - $19,375
2,106 New
2,106 $12,000
Q1 2018

May 11, 2018

SELL
$9.47 - $12.98 $316,468 - $433,765
-33,418 Closed
0 $0
Q4 2017

Feb 06, 2018

BUY
$8.45 - $17.48 $206,120 - $426,389
24,393 Added 270.28%
33,418 $330,000
Q3 2017

Nov 07, 2017

BUY
$13.52 - $23.75 $122,018 - $214,343
9,025
9,025 $133,000

About Syros Pharmaceuticals, Inc.


  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.